SNII Área II FARMACOLOGÍA HUMANA 65 JIMENEZ OROZCO, FAUSTO ALEJANDRO
JIMENEZ OROZCO, FAUSTO ALEJANDRO

JIMENEZ OROZCO, FAUSTO ALEJANDRO

CIENCIAS BIOMÉDICAS · Nivel 1

Desde 1995 es Profesor, PhD en Universidad Nacional Autónoma de México Facultad de Medicina

Información*

Nombre FAUSTO ALEJANDRO JIMENEZ OROZCO
Área BIOLOGÍA Y QUÍMICA
Campo CIENCIAS BIOMÉDICAS
Disciplina FARMACOLOGÍA HUMANA
Especialidad FARMACODINAMIA
CVU 21812
Institución
Dependencia SECRETARIA GENERAL
Entidad CIUDAD DE MEXICO
Nivel 1
Vigencia Inicio: 01/01/2023
Fin: 31/12/2027

* Información del primer trimestre de 2026.
Fuente: SECIHTI.

Publicaciones ORCID

2026
Chemically Defined Medium Enables GDNF-Driven Early Neuronal-like Phenotype of Human Dental Pulp Stem Cells Cells
Structure Activity Relationships of Multitarget Coumarins on Inhibitory Aggregation of Platelets: An Integrated In Vitro and In Silico Study Biophysica
2024
Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics
2022
Monosubstituted Coumarins Inhibit Epinephrine-induced Platelet Aggregation Cardiovascular and Hematological Agents in Medicinal Chemistry
2020
The predictivity of the -alert performance- functionality of the OECD QSAR-Toolbox (c/w further issues on the predictivity of nonclinical testing) Toxicology in Vitro
In vitro anti‑proliferative effect and in vivo antitumor action of daphnetin in different tumor cells Cirugía y Cirujanos
Drug excipients, food additives, and cosmetic ingredients probably not carcinogenic to humans reveal a functional specificity for the 2-year rodent bioassay Journal of Applied Toxicology
Insights into toxicology, safety pharmacology, and drug dependence testing: The performance and predictive values of nonclinical tests Journal of Pharmacological and Toxicological Methods
The 2-year rodent bioassay in drug and chemical carcinogenesis testing: Sensitivity, according to the framework of carcinogenic action Toxicology Mechanisms and Methods
2019
Combination of pentoxifylline and α-galactosylceramide with radiotherapy promotes necro-apoptosis and leukocyte infiltration and reduces the mitosis rate in murine melanoma